Heart failure with preserved ejection fraction (HFpEF) is a condition with complex pathophysiology and clinical profile. No treatment has been proven to reduce mortality or reduce morbidity in a meaningful way. In the era of percutaneous cardiac interventions, a novel method of reducing left atrial pressure by creating an iatrogenic interatrial shunt has been introduced. We present a report of implantation of InterAtrial Shunt Device (IASD®) in three consecutive patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5603/KP.a2017.0096 | DOI Listing |
Publication Analysis
Top Keywords
interatrial shunt
12
shunt device
8
device iasd®
8
heart failure
8
failure preserved
8
preserved ejection
8
ejection fraction
8
iasd® implantation
4
implantation novel
4
novel treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!